Literature DB >> 30242396

Association of Exfoliation Syndrome With Risk of Indirect Inguinal Hernia: The Utah Project on Exfoliation Syndrome.

Brian M Besch1, Karen Curtin1,2, Robert Ritch3, R Rand Allingham4, Barbara M Wirostko1.   

Abstract

Importance: Exfoliation syndrome (XFS) is a systemic connective tissue disease, and abnormal connective tissue metabolism is implicated in inguinal hernias (IH). Associating XFS with comorbid conditions may illuminate their underlying pathophysiology and affect clinical screening and treatment. Exfoliation syndrome involves altered systemic extracellular matrix (ECM) homeostasis involving elastin metabolism. Hernias occur owing to abnormal ECM synthesis, metabolism, or repair. Inguinal hernias involve weakening or rupture of the abdominal/groin wall. Objective: To determine an association between patients with XFS and patients with IH in Utah, possibly differing between direct or indirect hernia. Design, Setting, and Participants: Cross-sectional study in a large health care system of Utah hospitals and clinics. Conditional logistic regression odds ratios were used to estimate risk of XFS in patients with IH overall and by subtype (direct or indirect) compared with control individuals. Codes specific to direct and indirect IH with additional medical records review of 186 procedures were used to classify IH subtypes that were not prespecified. Bootstrap resampling with jackknife estimation used to calculate 95% confidence intervals. The model accounted for matching on sex and age and adjusted for body mass index and tobacco use. Population-based sample using medical records from 1996 to 2015 that identified 2594 patients 40 years or older on January 1, 1996, with surgical IH repair and 12 966 random control patients with no IH history matched 5:1 on sex and birth year. Data were analyzed between September 10, 2017, and October 23, 2017. Main Outcomes and Measures: Exfoliation syndrome outcome defined by diagnosis codes for XFS or exfoliation glaucoma from 1996 to 2015.
Results: Participants were primarily white (2532 of 2594 patients, [96.1%]; 12 454 of 12 966 control individuals [97.6%]) and non-Hispanic (2396 of 2594 patients [92.4%]); 250 participants were women (9.6%). Of study participants, 22 patients with IH and 43 control individuals were diagnosed as having XFS, respectively. Patients with IH had a 2.3-fold risk for an XFS diagnosis compared with control individuals (95% CI, 1.4-3.5; P = .03), and XFS risk with indirect IH appeared especially pronounced. Conclusions and Relevance: Inguinal hernia was associated with an increased risk of XFS in this Utah population. Further work is needed to understand the pathophysiology, genetics, and environmental factors contributing to both diseases.

Entities:  

Mesh:

Year:  2018        PMID: 30242396      PMCID: PMC6583040          DOI: 10.1001/jamaophthalmol.2018.4157

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  47 in total

1.  The effect of tobacco use on outcomes of laparoscopic and open inguinal hernia repairs: a review of the NSQIP dataset.

Authors:  MacKenzie Landin; John C Kubasiak; Scott Schimpke; Jennifer Poirier; Jonathan A Myers; Keith W Millikan; Minh B Luu
Journal:  Surg Endosc       Date:  2016-06-28       Impact factor: 4.584

2.  Exfoliation syndrome-the most common identifiable cause of open-angle glaucoma.

Authors:  R Ritch
Journal:  J Glaucoma       Date:  1994       Impact factor: 2.503

Review 3.  Patient-related risk factors for recurrence after inguinal hernia repair: a systematic review and meta-analysis of observational studies.

Authors:  Jakob Burcharth; Hans-Christian Pommergaard; Thue Bisgaard; Jacob Rosenberg
Journal:  Surg Innov       Date:  2014-09-30       Impact factor: 2.058

4.  A histopathologic study of iris changes in pseudoexfoliation syndrome.

Authors:  N Asano; U Schlötzer-Schrehardt; G O Naumann
Journal:  Ophthalmology       Date:  1995-09       Impact factor: 12.079

5.  Lysyl oxidase like-1 dysregulation and its contribution to direct inguinal hernia.

Authors:  G Pascual; M Rodríguez; R P Mecham; P Sommer; J Buján; J M Bellón
Journal:  Eur J Clin Invest       Date:  2009-04       Impact factor: 4.686

6.  Elastic fiber homeostasis requires lysyl oxidase-like 1 protein.

Authors:  Xiaoqing Liu; Yun Zhao; Jiangang Gao; Basil Pawlyk; Barry Starcher; Jeffrey A Spencer; Hiromi Yanagisawa; Jian Zuo; Tiansen Li
Journal:  Nat Genet       Date:  2004-01-25       Impact factor: 38.330

7.  The etiology of indirect inguinal hernias: congenital and/or acquired?

Authors:  K J P van Wessem; M P Simons; P W Plaisier; J F Lange
Journal:  Hernia       Date:  2003-03-18       Impact factor: 4.739

8.  Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.

Authors:  Gudmar Thorleifsson; Kristinn P Magnusson; Patrick Sulem; G Bragi Walters; Daniel F Gudbjartsson; Hreinn Stefansson; Thorlakur Jonsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Gerdur Stefansdottir; Gisli Masson; Gudmundur A Hardarson; Hjorvar Petursson; Arsaell Arnarsson; Mehdi Motallebipour; Ola Wallerman; Claes Wadelius; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Fridbert Jonasson; Kari Stefansson
Journal:  Science       Date:  2007-08-09       Impact factor: 47.728

9.  Risk for Exfoliation Syndrome in Women With Pelvic Organ Prolapse : A Utah Project on Exfoliation Syndrome (UPEXS) Study.

Authors:  Barbara M Wirostko; Karen Curtin; Robert Ritch; Samuel Thomas; Kristina Allen-Brady; Ken R Smith; Gregory S Hageman; R Rand Allingham
Journal:  JAMA Ophthalmol       Date:  2016-11-01       Impact factor: 7.389

10.  Tobacco use is not associated with groin hernia repair, a population-based study.

Authors:  A Hemberg; H Holmberg; M Norberg; P Nordin
Journal:  Hernia       Date:  2017-05-11       Impact factor: 4.739

View more
  6 in total

1.  Macula Vessel Density and Foveal Avascular Zone Parameters in Exfoliation Glaucoma Compared to Primary Open-Angle Glaucoma.

Authors:  Shawn Philip; Ahmad Najafi; Apichat Tantraworasin; Toco Y P Chui; Richard B Rosen; Robert Ritch
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-03-01       Impact factor: 4.799

2.  The protective variant rs7173049 at LOXL1 locus impacts on retinoic acid signaling pathway in pseudoexfoliation syndrome.

Authors:  Daniel Berner; Ursula Hoja; Matthias Zenkel; James Julian Ross; Steffen Uebe; Daniela Paoli; Paolo Frezzotti; Robyn M Rautenbach; Ari Ziskind; Susan E Williams; Trevor R Carmichael; Michele Ramsay; Fotis Topouzis; Anthi Chatzikyriakidou; Alexandros Lambropoulos; Periasamy Sundaresan; Humaira Ayub; Farah Akhtar; Raheel Qamar; Juan C Zenteno; Marisa Cruz-Aguilar; Yury S Astakhov; Michael Dubina; Janey Wiggs; Mineo Ozaki; Friedrich E Kruse; Tin Aung; André Reis; Chiea Chuen Khor; Francesca Pasutto; Ursula Schlötzer-Schrehardt
Journal:  Hum Mol Genet       Date:  2019-08-01       Impact factor: 6.150

Review 3.  Changes in peri-ocular anatomy and physiology in pseudoexfoliation syndrome (Review).

Authors:  Efstathios T Detorakis; Georgios Bontzos; Eleni E Drakonaki; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2021-04-19       Impact factor: 2.447

4.  Exfoliation Syndrome in Baja Verapaz Guatemala: A Cross-Sectional Study and Review of the Literature.

Authors:  Chase Paulson; Samuel C Thomas; Orlando Gonzalez; Samuel Taylor; Cole Swiston; Jennifer S Herrick; Lori McCoy; Karen Curtin; Craig J Chaya; Brian C Stagg; Barbara M Wirostko
Journal:  J Clin Med       Date:  2022-03-24       Impact factor: 4.241

5.  Association between Obstructive Sleep Apnea and Exfoliation Syndrome: The Utah Project on Exfoliation Syndrome.

Authors:  Caleb Shumway; Karen Curtin; Sam Taylor; Krishna M Sundar; Barbara M Wirostko; Robert Ritch
Journal:  Ophthalmol Glaucoma       Date:  2020-09-30

Review 6.  A Case-Cohort Study of Exfoliation Risk Factors and Literature Review.

Authors:  Ahmad M Mansour; Anastasios G P Konstas; Hana A Mansour; Abdul R Charbaji; Khalil M El Jawhari
Journal:  Middle East Afr J Ophthalmol       Date:  2021-04-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.